Exploratory Study on the Effects of Lung Insufflation Capacity Training Using the LIC Trainer in Patients With Amyotrophic Lateral Sclerosis: A Single-Center Prospective Interventional Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
- 试验地点
- 2
- 主要终点
- Overall survival (time to tracheostomy or death)
研究概览
简要总结
The goal of this clinical trial is to determine whether lung insufflation capacity (LIC) training can help maintain respiratory function and prolong tracheostomy-free survival in people with amyotrophic lateral sclerosis (ALS).
The main questions are:
Does early and continuous LIC training slow the decline in forced vital capacity (FVC)? Does LIC training prolong the time to tracheostomy or death?
This single-center study at the National Center of Neurology and Psychiatry (NCNP) in Japan will enroll 25 adults with ALS diagnosed according to the El Escorial or Awaji criteria. This is a single-arm study with no concurrently enrolled control group. Comparative analyses will use matched external controls. PRO-ACT will be used primarily to evaluate short-term respiratory-function trajectories, while JACALS, if data access is approved, will be used primarily to evaluate long-term time-to-event outcomes.
Participants will:
- Use the LIC Trainer device to perform lung insufflation training twice daily at home
- Visit the clinic every 3 months for respiratory and functional assessments
- Undergo respiratory tests, including FVC, LIC, maximum insufflation capacity (MIC), and cough peak flow (CPF)
- Complete the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R)
详细描述
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by upper and lower motor neuron degeneration, leading to muscle weakness, functional decline, and ultimately respiratory failure. Respiratory muscle weakness causes restrictive ventilatory impairment and a progressive decrease in forced vital capacity (FVC), which is strongly associated with survival. Because no curative therapy exists, respiratory rehabilitation aimed at maintaining pulmonary function and chest wall compliance plays an important role in extending quality of life and survival.
Lung volume recruitment therapy (LVRT) is a respiratory rehabilitation method that uses assisted lung inflation to expand the lungs and maintain compliance. It is commonly performed with a manual resuscitation bag (bag-valve-mask, BVM) by stacking multiple breaths to reach maximum insufflation capacity (MIC). However, this conventional method requires voluntary glottic closure to maintain air stacking. In people with ALS who have bulbar symptoms or tracheostomy, this ability is often lost, making conventional LVRT difficult or impossible.
To overcome this limitation, a device-based approach known as lung insufflation capacity (LIC) training was developed. The LIC Trainer is a licensed medical device in Japan that allows air stacking through a one-way valve mechanism, enabling passive insufflation without voluntary glottic control. The device incorporates a safety valve that automatically opens at pressures above 60 cmH₂O to prevent barotrauma and a manual relief valve allowing patient-controlled exhalation. Although the LIC Trainer has been used clinically in Japan since 2016, evidence regarding its long-term effects in ALS remains limited.
This prospective single-center interventional study aims to evaluate the effects of LIC training on respiratory function and survival in adults with ALS at the National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan. Participants are diagnosed with ALS according to the El Escorial or Awaji criteria, are 20 years of age or older, and are not using noninvasive ventilation (NIV) and do not have a tracheostomy at the start of LIC training. Key exclusion criteria include other chronic pulmonary diseases, severe cardiac dysfunction, and conditions that preclude study assessments.
After providing written informed consent, participants receive education on LIC training from a physical therapist and are provided with an LIC Trainer and bag-valve-mask for home use. They are instructed to perform a set of insufflation cycles, typically around 10 per session, twice daily. Training logs are maintained by participants and reviewed at each visit to monitor adherence and safety. Outpatient follow-up visits occur every 3 months for up to 36 months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
盲法说明
All participants and investigators are aware of the intervention. No blinding is applied.
入排标准
- 年龄范围
- 20 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 20 years or older
- •Diagnosis of amyotrophic lateral sclerosis (ALS) according to the El Escorial or Awaji criteria
- •Not using noninvasive ventilation (NIV) and without tracheostomy at the start of LIC training
- •Able to perform study assessments and provide written informed consent (or assisted signature with communication aid)
排除标准
- •Chronic pulmonary disease other than ALS (e.g., COPD, interstitial lung disease)
- •Severe cognitive or communication impairment preventing study participation
- •Uncontrolled cardiovascular disease, including unstable angina, recent myocardial infarction, decompensated heart failure, serious arrhythmia, severe aortic stenosis, or active myocarditis/endocarditis
- •Uncontrolled hypertension
- •Acute systemic illness or fever
- •Recent pulmonary embolism, acute cor pulmonale, or severe pulmonary hypertension
- •Severe hepatic or renal dysfunction
- •Any condition judged inappropriate by the investigator
研究组 & 干预措施
LIC Training
Participants with amyotrophic lateral sclerosis (ALS) will perform lung insufflation capacity (LIC) training using the LIC Trainer device to maintain lung and chest wall compliance. Each session consists of about 10 assisted insufflations performed twice daily at home. Physical therapists provide initial instruction and re-evaluation every 3 months during the 36-month follow-up period. The intervention aims to preserve pulmonary function, reduce respiratory complications, and prolong survival.
干预措施: LIC Trainer (Lung Insufflation Capacity Trainer) (Device)
结局指标
主要结局
Overall survival (time to tracheostomy or death)
时间窗: From the start of LIC training (Day 0) until tracheostomy or death, up to 36 months
Overall survival is defined as the time from the initiation of lung insufflation capacity (LIC) training to tracheostomy or death, whichever occurs first. Participants who remain alive without tracheostomy at the end of follow-up will be censored at their last known assessment. Survival analysis will use Kaplan-Meier estimates and Cox proportional hazards models. The outcome will also be compared with matched historical controls from the PRO-ACT ALS database using propensity score matching.
次要结局
- Change in forced vital capacity (%FVC)(Baseline and every 3 months for up to 36 months)
- Change in lung insufflation capacity (LIC) and maximum insufflation capacity (MIC)(Baseline and every 3 months for up to 36 months)
- Change in cough peak flow (CPF) and assisted CPF(Baseline and every 3 months for up to 36 months)
- Change in forced vital capacity (%FVC)(Baseline and every 3 months for up to 36 months)
- Change in cough peak flow (CPF) and assisted CPF(Baseline and every 3 months for up to 36 months)
- Change in lung insufflation capacity (LIC) and maximum insufflation capacity (MIC)(Baseline and every 3 months for up to 36 months)
- Change in ALS Functional Rating Scale-Revised (ALSFRS-R) score(Baseline and every 3 months for up to 36 months)
- Incidence of respiratory infections(Up to 36 months)
研究者
Taiyo Kawaguchi
Physician, Department of Rehabilitation Medicine
National Center of Neurology and Psychiatry, Japan
